Guardant Health (GH) Short Interest Ratio & Short Volume → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free GH Stock Alerts $27.02 +1.27 (+4.93%) (As of 01:33 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Guardant Health Short Interest DataCurrent Short Volume10,160,000 sharesPrevious Short Volume9,560,000 sharesChange Vs. Previous Month+6.28%Dollar Volume Sold Short$182.88 millionShort Interest Ratio / Days to Cover5.3Last Record DateApril 30, 2024Outstanding Shares122,370,000 sharesPercentage of Shares Shorted8.30%Today's Trading Volume1,616,802 sharesAverage Trading Volume1,928,632 sharesToday's Volume Vs. Average84% Short Selling Guardant Health ? Sign up to receive the latest short interest report for Guardant Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGH Short Interest Over TimeGH Days to Cover Over TimeGH Percentage of Float Shorted Over Time Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Guardant Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,160,000 shares $182.88 million +6.3%N/A5.3 $18.00 4/15/20249,560,000 shares $163.09 million +25.1%N/A4.8 $17.06 3/31/20247,640,000 shares $157.61 million -1.6%N/A4 $20.63 3/15/20247,760,000 shares $137.66 million +10.1%N/A4.8 $17.74 2/29/20247,050,000 shares $133.95 million +24.1%N/A4.3 $19.00 2/15/20245,680,000 shares $125.70 million +2.5%N/A3.6 $22.13 Get the Latest News and Ratings for GH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter. 1/31/20245,540,000 shares $121.49 million +4.1%N/A3.5 $21.93 1/15/20245,320,000 shares $128.74 million +1.7%N/A3.2 $24.20 12/31/20235,230,000 shares $141.47 million -4.7%N/A3.3 $27.05 12/15/20235,490,000 shares $154.76 million -4.4%N/A3.3 $28.19 11/30/20235,740,000 shares $144.48 million -9.5%N/A3.4 $25.17 11/15/20236,340,000 shares $144.68 million -9.4%N/A3.5 $22.82 10/31/20237,000,000 shares $181.16 million -5.0%N/A4.2 $25.88 10/15/20237,370,000 shares $199.21 million +5.1%N/A4.6 $27.03 9/30/20237,010,000 shares $207.78 million +1.5%N/A4.5 $29.64 9/15/20236,910,000 shares $204.05 million -1.4%N/A4.5 $29.53 8/31/20237,010,000 shares $273.95 million +2.5%N/A4 $39.08 8/15/20236,840,000 shares $242.07 million -8.2%N/A3.4 $35.39 7/31/20237,450,000 shares $290.70 million -9.3%N/A3.4 $39.02 7/15/20238,210,000 shares $314.61 million -4.8%N/A3.8 $38.32 6/30/20238,620,000 shares $308.60 million +13.1%N/A4 $35.80 6/15/20237,620,000 shares $288.49 million +10.0%N/A3.5 $37.86 5/31/20236,930,000 shares $203.19 million -2.4%N/A3.4 $29.32 5/15/20237,100,000 shares $198.02 million +11.1%7.3%3.5 $27.89 4/30/20236,390,000 shares $144.16 million -8.6%6.5%3.3 $22.56 4/15/20236,990,000 shares $171.26 million +3.4%7.2%3.7 $24.50 3/31/20236,760,000 shares $158.45 million +7.1%6.9%3.4 $23.44 3/15/20236,310,000 shares $168.98 million -9.9%6.5%3.1 $26.78 2/28/20237,000,000 shares $216.23 million +13.1%7.2%3.4 $30.89 2/15/20236,190,000 shares $179.32 million +11.9%6.3%3.2 $28.97 1/31/20235,530,000 shares $173.81 million -0.4%6.1%3.3 $31.43 1/15/20235,550,000 shares $168.89 million +8.8%5.7%3.5 $30.43 12/30/20225,100,000 shares $138.72 million +18.9%5.3%3.3 $27.20 12/15/20224,290,000 shares $177.01 million +3.9%4.4%3.1 $41.26 11/30/20224,130,000 shares $216.16 million -1.9%4.3%4.1 $52.34 11/15/20224,210,000 shares $215.76 million +5.5%4.4%4.1 $51.25 10/31/20223,990,000 shares $197.51 million +1.8%4.1%4 $49.50 10/15/20223,920,000 shares $191.14 million +4.3%4.1%4 $48.76 9/30/20223,760,000 shares $202.40 million -12.2%3.9%4.1 $53.83 9/15/20224,280,000 shares $252.05 million -7.2%4.5%4.6 $58.89This is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects GH Short Interest - Frequently Asked Questions What is Guardant Health's current short interest? Short interest is the volume of Guardant Health shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 10,160,000 shares of GH short. Learn More on Guardant Health's current short interest. What is a good short interest ratio for Guardant Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GH shares currently have a short interest ratio of 5.0. Learn More on Guardant Health's short interest ratio. Which institutional investors are shorting Guardant Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Guardant Health: Torno Capital LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Guardant Health's short interest increasing or decreasing? Guardant Health saw a increase in short interest in April. As of April 30th, there was short interest totaling 10,160,000 shares, an increase of 6.3% from the previous total of 9,560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guardant Health's short interest compare to its competitors? Here is how the short interest of companies compare to Guardant Health: Fortrea Holdings Inc. (7.41%), RadNet, Inc. (4.36%), Veracyte, Inc. (5.74%), Viridian Therapeutics, Inc. (14.59%), CareDx, Inc (10.57%), Fulgent Genetics, Inc. (3.48%), Genetron Holdings Limited (0.08%), Burning Rock Biotech Limited (0.47%), Personalis, Inc. (3.03%), Exact Sciences Co. (4.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Guardant Health stock? Short selling GH is an investing strategy that aims to generate trading profit from Guardant Health as its price is falling. GH shares are trading up $1.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guardant Health? A short squeeze for Guardant Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GH, which in turn drives the price of the stock up even further. How often is Guardant Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GH, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: FTRE Short Interest Data RDNT Short Interest Data VCYT Short Interest Data VRDN Short Interest Data CDNA Short Interest Data FLGT Short Interest Data GTH Short Interest Data BNR Short Interest Data PSNL Short Interest Data EXAS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GH) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research